68.25
price down icon1.65%   -1.145
after-market Handel nachbörslich: 68.25
loading
Schlusskurs vom Vortag:
$69.39
Offen:
$69.24
24-Stunden-Volumen:
687.91K
Relative Volume:
1.03
Marktkapitalisierung:
$3.76B
Einnahmen:
$76.81M
Nettoeinkommen (Verlust:
$-162.42M
KGV:
-22.83
EPS:
-2.99
Netto-Cashflow:
$-122.49M
1W Leistung:
+0.15%
1M Leistung:
+8.33%
6M Leistung:
+3.64%
1J Leistung:
+8.38%
1-Tages-Spanne:
Value
$66.52
$69.24
1-Wochen-Bereich:
Value
$66.52
$71.58
52-Wochen-Spanne:
Value
$47.86
$107.37

Arcellx Inc Stock (ACLX) Company Profile

Name
Firmenname
Arcellx Inc
Name
Telefon
240-327-0603
Name
Adresse
800 BRIDGE PARKWAY, REDWOOD CITY
Name
Mitarbeiter
163
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
ACLX's Discussions on Twitter

Vergleichen Sie ACLX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ACLX
Arcellx Inc
68.25 3.76B 76.81M -162.42M -122.49M -2.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Arcellx Inc Stock (ACLX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-17 Eingeleitet Citigroup Buy
2024-10-08 Eingeleitet Redburn Atlantic Buy
2024-09-03 Eingeleitet Cantor Fitzgerald Overweight
2024-05-31 Eingeleitet Piper Sandler Overweight
2024-03-07 Eingeleitet Morgan Stanley Overweight
2024-01-04 Bestätigt Needham Buy
2023-12-19 Eingeleitet Scotiabank Sector Outperform
2023-10-30 Eingeleitet TD Cowen Outperform
2023-10-17 Eingeleitet UBS Buy
2023-05-18 Eingeleitet Truist Buy
2023-04-14 Eingeleitet Robert W. Baird Outperform
2023-03-14 Eingeleitet Stifel Buy
2023-02-13 Eingeleitet H.C. Wainwright Buy
2022-12-13 Fortgesetzt BofA Securities Buy
2022-10-31 Eingeleitet Guggenheim Buy
2022-10-27 Eingeleitet Needham Buy
2022-07-20 Eingeleitet Canaccord Genuity Buy
2022-03-01 Eingeleitet BofA Securities Buy
2022-03-01 Eingeleitet SVB Leerink Outperform
Alle ansehen

Arcellx Inc Aktie (ACLX) Neueste Nachrichten

pulisher
12:11 PM

What analysts say about Arcellx Inc. stockTriple-digit profit margins - jammulinksnews.com

12:11 PM
pulisher
Jul 22, 2025

What drives Arcellx Inc. stock priceUnrivaled growth potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Arcellx Inc. a good long term investmentFree Trading Strategy Suggestions - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Bank of New York Mellon Corp Cuts Position in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jul 22, 2025
pulisher
Jul 21, 2025

Principal Financial Group Inc. Sells 184 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

Xponance Inc. Acquires 190 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jul 20, 2025
pulisher
Jul 17, 2025

There's Reason For Concern Over Arcellx, Inc.'s (NASDAQ:ACLX) Price - 富途牛牛

Jul 17, 2025
pulisher
Jul 17, 2025

Arcellx Advances Phase 3 Study for Multiple Myeloma Treatment - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Teacher Retirement System of Texas Decreases Stake in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jul 17, 2025
pulisher
Jul 15, 2025

Arcellx; Anito-Cel With D-Domain Differentiation Looks To Capture R/R MM Market (ACLX) - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Arcellx Inc. stock price move sharplyElite Stock Shortlist - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Arcellx Inc. stock attracts strong analyst attentionFree High-Accuracy Stock Picks - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

GAMMA Investing LLC Buys 252 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jul 12, 2025
pulisher
Jul 12, 2025

Amalgamated Bank Buys 161 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

Allspring Global Investments Holdings LLC Has $468,000 Stock Position in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jul 11, 2025
pulisher
Jul 09, 2025

How might ACLX's 2025 Q1 EPS forecast affect strategies? - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

Piper Sandler maintains Overweight rating on Arcellx stock amid CAR-T safety study - Investing.com Nigeria

Jul 08, 2025
pulisher
Jun 30, 2025

FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers - Benzinga

Jun 30, 2025
pulisher
Jun 23, 2025

(ACLX) Trading Signals - news.stocktradersdaily.com

Jun 23, 2025
pulisher
Jun 17, 2025

Citi initiates Arcellx stock with buy rating on cell therapy potential - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Citi initiates Arcellx stock with buy rating on cell therapy potential By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

Cancer Cell Market Exclusive Report with Detailed Study Analysis | Abbott Laboratories, Cellectis, Arcellx, GE - newstrail.com

Jun 17, 2025
pulisher
Jun 17, 2025

Citigroup Initiates Arcellx at Buy With $110 Price Target - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Arcellx initiated with a Buy at Citi - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Arcellx (ACLX): Citi Initiates Buy Rating with Promising Outlook | ACLX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Aileen Fernandes | People on The MoveSan Francisco Business Times - The Business Journals

Jun 16, 2025
pulisher
Jun 16, 2025

Aileen Fernandes - The Business Journals

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Anito-cel: A Promising Market Entrant with Superior Efficacy and Safety in Multiple Myeloma Treatment - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Anito Cel Therapy: A Promising Contender in Multiple Myeloma Treatment with Strong Market Potential - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

ACLX: HC Wainwright & Co. Reiterates Buy Rating with $115 Target | ACLX Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx stock maintains buy rating at H.C. Wainwright on launch plans - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Strategic Partnership with Kite Enhances Anito-cel Therapy Launch and Market Position - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Promising Potential of Arcellx Inc’s Anito-cel Therapy Drives Buy Rating - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Positive Outlook for Arcellx Inc: Promising Anito-cel Therapy and Strategic Market Positioning - TipRanks

Jun 16, 2025

Finanzdaten der Arcellx Inc-Aktie (ACLX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):